BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17993599)

  • 1. Postconditioning fails to improve no reflow or alter infarct size in an open-chest rabbit model of myocardial ischemia-reperfusion.
    Hale SL; Mehra A; Leeka J; Kloner RA
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H421-5. PubMed ID: 17993599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):226-32. PubMed ID: 18625805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
    Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothermia during reperfusion limits 'no-reflow' injury in a rabbit model of acute myocardial infarction.
    Hale SL; Dae MW; Kloner RA
    Cardiovasc Res; 2003 Sep; 59(3):715-22. PubMed ID: 14499873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
    Reffelmann T; Hale SL; Li G; Kloner RA
    Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed treatment with hypothermia protects against the no-reflow phenomenon despite failure to reduce infarct size.
    Hale SL; Herring MJ; Kloner RA
    J Am Heart Assoc; 2013 Jan; 2(1):e004234. PubMed ID: 23525431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model.
    Dai W; Hale S; Kloner RA
    Int J Cardiol; 2017 Jun; 236():400-404. PubMed ID: 28108128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
    Uitterdijk A; Sneep S; van Duin RW; Krabbendam-Peters I; Gorsse-Bakker C; Duncker DJ; van der Giessen WJ; van Beusekom HM
    Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1104-10. PubMed ID: 23873799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion.
    Hale SL; Kloner RA
    J Thromb Thrombolysis; 2015 Jan; 39(1):50-4. PubMed ID: 25017632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined remote perconditioning and postconditioning failed to attenuate infarct size and contractile dysfunction in a rat model of coronary artery occlusion.
    Sachdeva J; Dai W; Gerczuk PZ; Kloner RA
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):567-73. PubMed ID: 24607766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
    Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
    Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective effects of angiotensin II type 1 receptor blockade with olmesartan on reperfusion injury in a rat myocardial ischemia-reperfusion model.
    Dai W; Hale SL; Kay GL; Jyrala AJ; Kloner RA
    Cardiovasc Ther; 2010; 28(1):30-7. PubMed ID: 20074257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in reperfusion length following 30 minutes of ischemia in the rabbit influence infarct size, as measured by triphenyltetrazolium chloride staining.
    Birnbaum Y; Hale SL; Kloner RA
    J Mol Cell Cardiol; 1997 Feb; 29(2):657-66. PubMed ID: 9140823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit.
    Reffelmann T; Kloner RA
    Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1099-107. PubMed ID: 12181140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote postconditioning. Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors.
    Kerendi F; Kin H; Halkos ME; Jiang R; Zatta AJ; Zhao ZQ; Guyton RA; Vinten-Johansen J
    Basic Res Cardiol; 2005 Sep; 100(5):404-12. PubMed ID: 15965583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion.
    Birnbaum Y; Patterson M; Kloner RA
    J Mol Cell Cardiol; 1997 Aug; 29(8):2013-25. PubMed ID: 9281435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits.
    Chiari PC; Bienengraeber MW; Pagel PS; Krolikowski JG; Kersten JR; Warltier DC
    Anesthesiology; 2005 Jan; 102(1):102-9. PubMed ID: 15618793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
    Hausenloy DJ; Chilian W; Crea F; Davidson SM; Ferdinandy P; Garcia-Dorado D; van Royen N; Schulz R; Heusch G
    Cardiovasc Res; 2019 Jun; 115(7):1143-1155. PubMed ID: 30428011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotection with adenosine-regulating agent, GP531: effects on no-reflow, infarct size, and blood flow following ischemia/ reperfusion in the rabbit.
    Hale SL; Kloner RA
    J Cardiovasc Pharmacol Ther; 2010 Mar; 15(1):60-7. PubMed ID: 20133497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.